Pfizer Files Q1 2025 10-Q Report
Ticker: PFE · Form: 10-Q · Filed: May 5, 2025 · CIK: 78003
| Field | Detail |
|---|---|
| Company | Pfizer Inc (PFE) |
| Form Type | 10-Q |
| Filed Date | May 5, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-Q, financials, pharmaceuticals
TL;DR
Pfizer's Q1 2025 10-Q is in: financials look steady, company continues pharma ops.
AI Summary
Pfizer Inc. filed its 10-Q for the period ending March 30, 2025. The filing details financial performance and operational updates for the first quarter of 2025. Key financial data and business segments are presented, reflecting the company's ongoing activities in the pharmaceutical sector.
Why It Matters
This report provides investors and analysts with the latest financial health and operational performance of Pfizer, a major pharmaceutical company, influencing investment decisions and market perception.
Risk Assessment
Risk Level: low — This is a routine quarterly financial filing with no immediate red flags or significant negative events indicated.
Key Numbers
- 2025-03-30 — Reporting Period End Date (Indicates the end of the financial quarter being reported.)
- 2025-01-01 — Reporting Period Start Date (Indicates the start of the financial quarter being reported.)
- 2024-12-31 — Previous Year End Date (Provides a comparison point to the end of the prior fiscal year.)
Key Players & Entities
- Pfizer Inc. (company) — Filer of the 10-Q report
- 20250330 (date) — End of the reporting period
- 20250505 (date) — Filing date of the report
- 2834 (dollar_amount) — Standard Industrial Classification code for Pharmaceutical Preparations
FAQ
What is the reporting period for this 10-Q filing?
The reporting period for this 10-Q filing is March 30, 2025.
When was this 10-Q filed with the SEC?
This 10-Q was filed on May 5, 2025.
What is Pfizer Inc.'s Standard Industrial Classification code?
Pfizer Inc.'s Standard Industrial Classification code is 2834, which corresponds to Pharmaceutical Preparations.
What is the fiscal year end for Pfizer Inc.?
Pfizer Inc.'s fiscal year ends on December 31.
What is the business address listed for Pfizer Inc.?
The business address listed for Pfizer Inc. is 66 Hudson Boulevard East, New York, NY 10001-2192.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on May 5, 2025 regarding PFIZER INC (PFE).